Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial

Timothy J. Ingall(World Health Organization), Teresa J. Christianson(Mayo Clinic), Thomas A. Louis(Johns Hopkins University), Kjell Asplund(Umeå University), W. Michael O’Fallon, Vicki Hertzberg(Emory University), Lewis R. Goldfrank(New York University)
Stroke
September 3, 2004
Cited by 253


Related Papers